Search Results - "Robles Diaz, L."

Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized Trials by Jiménez-Fonseca, P., Sastre, J., García-Alfonso, P., Gómez-España, M.A., Salud, A., Gil, S., Rivera, F., Reina, J.J., Quintero, G., Valladares-Ayerbes, M., Safont, M.J., La Casta, A., Robles-Díaz, L., García-Paredes, B., López López, R., Guillot, M., Gallego, J., Alonso-Orduña, V., Diaz-Rubio, E., Aranda, E.

“…The bCTC count is a well-established prognostic biomarker in mCRC, as well as in other tumor types. The aim of this analysis was to evaluate the…”
Get full text

DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas by Kamieniak, M M, Muñoz-Repeto, I, Rico, D, Osorio, A, Urioste, M, García-Donas, J, Hernando, S, Robles-Díaz, L, Ramón y Cajal, T, Cazorla, A, Sáez, R, García-Bueno, J M, Domingo, S, Borrego, S, Palacios, J, van de Wiel, M A, Ylstra, B, Benítez, J, García, M J

“…Background: Few studies have attempted to characterise genomic changes occurring in hereditary epithelial ovarian carcinomas (EOCs) and inconsistent results…”
Get full text

Seasonal distribution and modeling of diesel particulate matter in the Southeast US by Díaz-Robles, L.A., Fu, J.S., Reed, G.D., DeLucia, A.J.

“…The fine and ultra fine size of diesel particulate mater (DPM) are of great health concern and significantly contribute to the overall cancer risk. In…”
Get full text

Modeling and source apportionment of diesel particulate matter by Díaz-Robles, L.A., Fu, J.S., Reed, G.D.

“…The fine and ultra fine sizes of diesel particulate matter (DPM) are of greatest health concern. The composition of these primary and secondary fine and ultra…”
Get full text

Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial by Santos, C., Azuara, D., Viéitez, J.M., Páez, D., Falcó, E., Élez, E., López-López, C., Valladares, M., Robles-Díaz, L., García-Alfonso, P., Bugés, C., Durán, G., Salud, A., Navarro, V., Capellá, G., Aranda, E., Salazar, R.

“…Several studies show the importance of accurately quantifying not only KRAS and other low-abundant mutations because benefits of anti-EGFR therapies may depend…”
Get full text

Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 study by Sastre, J., García-Alfonso, P., Viéitez, J.M., Cano, M.T., Rivera, F., Reina-Zoilo, J.J., Salud-Salvia, A., Quintero, G., Robles-Díaz, L., Safont, M.J., La Casta, A., Gil, S., Polo, E., Asensio-Martínez, E., García-Paredes, B., López, R.L., Guillot, M., Valladares-Ayerbes, M., Aranda, E., Díaz-Rubio, E., Viéitez, J.M., Jiménez, P., Aguilar, E. Aranda, Gómez, A., Gil Calle, S., Salud, A., Valladares, M., Graña, B., García-Alfonso, P., Rivera, F., Quintero, G., Reina, J.J., González Flores, E., Salgado, M., Grande, E., Guillén, C., Garcia Carbonero, R., Flor, M.J., Safont, M.J., La Casta, A., Arévalo, S., Sastre, J., López López, R., Manzano, H., Guillot, M., Hernández Yagüe, X., Arrivi, A., Falcó, E., Gallego, J., Escudero, P., Cabezas, I., Juárez, A., Gálvez, E., Grávalos, C., Robles, L., Polo, E., Dueñas, R., Campos, J.M., Albert, A., Salinas, P., Montagut, C., Provencio, M., Ruiz Casado, A., Muñoz, J., Gil Raga, M., Chilet, M.R., González González, F.J., Massutí, B., López, A., Aparicio, J., Marín, M., Alfaro, J., Zanui, M., Gutiérrez Abad, D., García Tapiador, A.M., García-Girón, C., Molina Saera, J., Torres Sánchez, E., López, I., Bosch, C., Valero, J., Martínez de Prado, P.

“…We explored the influence of BRAF and PIK3CA mutational status on the efficacy of bevacizumab or cetuximab plus 5-fluorouracil/leucovorin and irinotecan…”
Get full text

Effect of hydrothermal carbonization on the properties, devolatilization, and combustion kinetics of Chilean biomass residues by Monedero, E., Lapuerta, M., Pazo, A., Díaz-Robles, L.A., Pino-Cortés, E., Campos, V., Vallejo, F., Cubillos, F., Gómez, J.

“…This work evaluates the hydrothermal carbonization (HTC) process as a method to upgrade the quality of biomass residues to be used as fuels in gasification or…”
Get full text

Emission Scenarios and the Health Risks Posed by Priority Mobile Air Toxics in an Urban to Regional Area: An Application in Nashville, Tennessee by L. A. Díaz-Robles, J. S. Fu, G. D. Reed

Get full text

A hybrid ARIMA and artificial neural networks model to forecast particulate matter in urban areas: The case of Temuco, Chile by Díaz-Robles, Luis A., Ortega, Juan C., Fu, Joshua S., Reed, Gregory D., Chow, Judith C., Watson, John G., Moncada-Herrera, Juan A.

“…Air quality time series consists of complex linear and non-linear patterns and are difficult to forecast. Box–Jenkins Time Series (ARIMA) and multilinear…”
Get full text

Actualización del cáncer de mama en Atención Primaria (III/V) by Álvarez Hernández, C, Vich Pérez, P, Brusint, B, Cuadrado Rouco, C, Díaz García, N, Robles Díaz, L

“…Resumen El cáncer de mama es una enfermedad prevalente con implicaciones en todas las esferas de la vida de las pacientes, por lo que el médico de familia debe…”
Get full text

Evaluation of potential gross income from non-timber products in a model riparian forest for the Chesapeake Bay watershed by Robles-Diaz-De-Leon, L.F. (Maryland Univ., College Park, MD (USA). Marine, Estuarine and Environmental Sciences Program), Kangas, P

“…The creation of riparian forest buffer zones for water quality management in agricultural landscapes takes land out of production, incurring an economic loss…”
Get full text

TP53 and CHEK2 1100delC gene mutation in North American families suggestive Li-Fraumeni syndrome: Memorial Sloan-Kettering experience by Siddiqui, R., Robles Diaz, L., Nafa, K., Kauff, N., Facio, F., Huang, H., Onel, K., Robson, M., Ellis, N., Offit, K.

“…Abstract only…”
Get full text

TP53 and CHEK2 1100delC gene mutation in North American families suggestive Li-Fraumeni syndrome: Memorial Sloan-Kettering experience by Siddiqui, R., Robles Diaz, L., Nafa, K., Kauff, N., Facio, F., Huang, H., Onel, K., Robson, M., Ellis, N., Offit, K.

“…Abstract only…”
Get full text

628PA META-ANALYSIS ON THE EFFICACY OF SECOND LINE (2L) TREATMENT OPTIONS FOR ADVANCED GASTRIC CANCER (AGC) by Riesco Martínez, M.C., Adeva Alfonso, J., Andrés Esteban, E., Gómez-Martín, C., Lema Roso, L., Robles Díaz, L., Parrilla Rubio, L., Ruiz-Ares, G., Pernaut Sánchez, C., López-Martín, J.A.

“…Abstract Aim: Different regimens of systemic chemotherapy (CT) and targeted therapy (TT) have proven to be effective in 2L AGC. No randomized clinical trials…”
Get full text

A Meta-Analysis on the Efficacy of Second Line (2L) Treatment Options for Advanced Gastric Cancer (Agc) by Riesco Martínez, M.C., Adeva Alfonso, J., Andrés Esteban, E., Gómez-Martín, C., Lema Roso, L., Robles Díaz, L., Parrilla Rubio, L., Ruiz-Ares, G., Pernaut Sánchez, C., López-Martín, J.A.

Get full text

Playing with Asimina triloba (pawpaw): a species to consider when enhancing riparian forest buffer systems with non-timber products by Fernanda Robles-Diaz-de-León, Luisa, Nava-Tudela, Alfredo

“…A dynamic model that depicts the growth, production and possible economical gains from Asimina triloba (pawpaw), a native North American fruit, is presented…”
Get full text

Ras Analysis of the Planet Study: Phase Ii Trial of Panitumumab (P) Plus Folfox4 or Folfiri in Subjects with Wild-Type (Wt) Kras Colorectal Cancer (Crc) and Liver-Limited Disease (Lld) by Abad, A., Sureda, B. Massuti, Grávalos, C., Escudero, P., Guillen-Ponce, C., Gómez, A., Safont, M.J., Plazas, J. Gallego, Sastre, J., Pericay, C., Dueñas, R., López, C., Losa, F., Valladares-Ayerbes, M., Flores, E. González, Díaz, L. Robles, Layos, L., Carrato, A., Aranda, E.

Get full text

551PRAS ANALYSIS OF THE PLANET STUDY: PHASE II TRIAL OF PANITUMUMAB (P) PLUS FOLFOX4 OR FOLFIRI IN SUBJECTS WITH WILD-TYPE (WT) KRAS COLORECTAL CANCER (CRC) AND LIVER-LIMITED DISEASE (LLD) by Abad, A., Sureda, B. Massuti, Grávalos, C., Escudero, P., Guillen-Ponce, C., Gómez, A., Safont, M.J., Plazas, J. Gallego, Sastre, J., Pericay, C., Dueñas, R., López, C., Losa, F., Valladares-Ayerbes, M., Flores, E. González, Díaz, L. Robles, Layos, L., Carrato, A., Aranda, E.

“…Abstract Aim: Patients (pts) with RAS mutations other than KRAS exon 2 do not benefit from P. We explored the effect of these mutations in the efficacy of…”
Get full text

Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial by Santos, C, Azuara, D, Viéitez, J M, Páez, D, Falcó, E, Élez, E, López-López, C, Valladares, M, Robles-Díaz, L, García-Alfonso, P, Bugés, C, Durán, G, Salud, A, Navarro, V, Capellá, G, Aranda, E, Salazar, R

“…Several studies show the importance of accurately quantifying not only KRAS and other low-abundant mutations because benefits of anti-EGFR therapies may depend…”
Get full text

Update of breast cancer in Primary Care (III/V) by Álvarez Hernández, C, Vich Pérez, P, Brusint, B, Cuadrado Rouco, C, Díaz García, N, Robles Díaz, L

“…Breast cancer is a prevalent disease with implications in all aspects of patientś life, therefore, family doctors must know this pathology in depth, in order…”
Get full text